4//SEC Filing
Schilke Tobin 4
Accession 0001479290-23-000083
CIK 0001479290other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:11 PM ET
Size
6.3 KB
Accession
0001479290-23-000083
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2023-06-30$15.61/sh+769$12,001→ 81,597 total - Sale
Common Stock
2023-07-03$25.04/sh−1,701$42,593→ 79,896 total
Footnotes (2)
- [F1]These shares were acquired by Mr. Schilke under the Issuer's 2014 Employee Stock Purchase Plan on June 30, 2023 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 18, 2022 by Mr. Schilke.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001678984
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 9:11 PM ET
- Size
- 6.3 KB